|
UGDH expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.643900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.820200E-04 |
| Normal-vs-Stage2 |
4.159200E-01 |
| Normal-vs-Stage3 |
3.897200E-01 |
| Normal-vs-Stage4 |
4.412000E-01 |
| Stage1-vs-Stage2 |
3.112200E-01 |
| Stage1-vs-Stage3 |
3.072800E-01 |
| Stage1-vs-Stage4 |
1.829710E-02 |
| Stage2-vs-Stage3 |
9.858800E-01 |
| Stage2-vs-Stage4 |
2.284600E-01 |
| Stage3-vs-Stage4 |
2.156400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.893180E-01 |
| Normal-vs-AfricanAmerican |
6.53839999920081E-08 |
| Normal-vs-Asian |
6.153800E-01 |
| Caucasian-vs-AfricanAmerican |
1.6460399999918E-05 |
| Caucasian-vs-Asian |
9.891400E-01 |
| AfricanAmerican-vs-Asian |
6.249700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.358190E-01 |
| Normal-vs-Female |
3.922300E-02 |
| Male-vs-Female |
4.857200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.944200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.877800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.772800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.787990E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.685400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.503000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.696600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.254800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.846820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.631900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.814000E-02 |
| Normal-vs-Grade 2 |
9.515200E-03 |
| Normal-vs-Grade 3 |
3.562200E-02 |
| Normal-vs-Grade 4 |
1.576550E-01 |
| Grade 1-vs-Grade 2 |
5.301400E-01 |
| Grade 1-vs-Grade 3 |
3.966000E-01 |
| Grade 1-vs-Grade 4 |
8.358400E-03 |
| Grade 2-vs-Grade 3 |
7.227400E-01 |
| Grade 2-vs-Grade 4 |
9.482300E-03 |
| Grade 3-vs-Grade 4 |
1.677780E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.750400E-04 |
| Normal-vs-ccB subtype |
9.533600E-01 |
| ccA subtype-vs-ccB subtype |
1.780260E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.701400E-01 |
| Normal-vs-N1 |
6.659600E-01 |
| N0-vs-N1 |
4.167800E-01 |
|
|
